Cosciens Biopharma Inc (CSCI)

$ALZN currently sitting on 5000 shares with enough dry powder to add 15,000 more at the right time. IMO this is a no brainer with a 90% short float and only 800,000 shares outstanding (short 710,000)... just add volume and BOOM!! $BCDA $CSCI $CVM $NEUP

$ALZN Are you feeling it?? looking for the SQUEEEZE!! $BCDA $CSCI $CVM $NEUP

$CSCI stopped?

$CSCI Looks like the proxy fight is over. https://www.globenewswire.com/news-release/2025/05/30/3091340/0/en/COSCIENS-Biopharma-Inc-Reconstitutes-Board-for-Benefit-of-Shareholders.html CSCI agreed to put 4 of Goodwood's nominees on the board - Anthony J. Giovinazzo, Peter H. Puccetti, Robert A. Seager and David Spear. Peter Puccetti, Chairman and Chief Investment Officer of Goodwood, will be CSCI's new board chairman.

$CSCI Cosciens Biopharma announces receipt of Goodwood intended director nominations Cosciens Biopharma confirmed that its board of directors has received a letter from Goodwood Fund and Puccetti Funds Management regarding six director nominations for the company's upcoming annual and special meeting of shareholders. "We respectfully acknowledge receipt of the statement regarding the intentions from Goodwood and are carefully reviewing its contents," said Ronnie Miller, Chair of the Board of Cosciens Biopharma. "With this in hand, the Board will evaluate and determine its path forward and remains fully committed to acting in the best interests of Cosciens and our shareholders." The company will continue to provide updates to shareholders related to this matter, it added.

$CSCI Looks like a proxy fight is brewing. https://www.newswire.ca/news-releases/goodwood-to-nominate-new-directors-for-cosciens-biopharma-inc--823979995.html Goodwood Fund, which owns 8.2% of CSCI, is nominating their own slate of 6 Directors for the Board. "Absent new board leadership, Goodwood believes that COSCIENS will continue its legacy of shareholder value destruction, irresponsible overspending, including on long-shot R&D programs, and broken promises. The current board of COSCIENS is out of ideas and out of time. In contrast, the Shareholder Nominees will provide COSCIENS with the leadership and strategic direction it requires moving forward. The Shareholder Nominees have a plan and vision to create shareholder value at COSCIENS, and they will quickly move to do so. They also have the skills, expertise and reputations for shareholders to be confident that the Shareholder Nominees will deliver. All COSCIENS shareholders can very much look forward to a revitalized COSCIENS under the stewardship of the Shareholder Nominees"

$CYCU $CHRO gappers and runner this morning $RTC $CSCI

$CSCI Que le pasa,que se mueve menos que los ojos del Espinete?

$CSCI this chat is dead. Crazy

$CSCI scam

#myCSCIanalysis $CSCI

$CSCI smell like a scam....

$CSCI Halt Time: 09:31:54 Issue Symbol: CSCI Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

$CSCI Cosciens Biopharma announces possible delay in filing 2024-end documents COSCIENS Biopharma "announced that there is a potential for delay in the filing of: (a) its annual financial statements as of December 31, 2024 and 2023 and for the years ended December 31, 2024, 2023 and 2022, and its related management's discussion and analysis; (b) the CEO and CFO certificates relating to the Financial Statements; and (c) the Company's annual information form, beyond the prescribed filing deadline, being March 31, 2025. The potential delay in filing of the Required Filings is a result of additional time that may be required to address certain matters related to the 2024 all stock merger transaction (the "Transaction") between the Company and Ceapro Inc. In connection with the Transaction, Ceapro, which was formerly listed on the TSX Venture Exchange, was required to undergo a conversion of its accounting procedures to ensure compliance with the Company's existing SEC reporting obligations and internal control requirements. This is first audit of the combined entity that has been required since the Transaction, which has not only added additional complexity to the audit process but also required additional time to complete the review of Ceapro's internal controls. As a result, there has been an unexpected volume of matters necessary to address in order for the Company's auditors to complete the audit."

https://nfne.ws/245339 $CSCI $CSCI.TSX @COSCIENSbio #Chemicals #Pharmaceutical #Medical #Pharmaceuticals #NASDAQ #TSX #Investing

$TNXP $XHLD $CSAI $CSCI When you know BEAR and SHORTS are burning! 💪🤑💸💱💰💹🚀🌋😘😘😘

$CSCI anyone know why this is going up so much....I am happy it is...but why???